XML 23 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Mar. 31, 2012
Mar. 31, 2011
Jun. 30, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]          
Revenues $ 230    $ 615      
Research and development expenses (3,427) (2,145) (9,271) (5,832) (8,311)
Less participation by the Office of the Chief Scientist and other parties 511 598 2,432 1,709 1,682
Research and development expenses, net (2,916) (1,547) (6,839) (4,123) (6,629)
General and administrative expenses (1,924) (1,152) (4,836) (3,154) (4,485)
Operating loss (4,610) (2,699) (11,060) (7,277) (11,114)
Financial income, net 436 86 401 154 266
Net loss for the period $ (4,174) $ (2,613) $ (10,659) $ (7,123) $ (10,848)
Loss per share:          
Basic and diluted net loss per share $ (0.09) $ (0.07) $ (0.24) $ (0.26) $ (0.35)
Weighted average number of shares used in computing basic and diluted net loss per share 44,328,201 36,676,721 43,585,104 27,894,392 31,198,825